4-Methyl-2,5-methoxyphenylcyclopropylamine
From Wikipedia, the free encyclopedia
(Redirected from DMCPA)
| Names | |
|---|---|
| IUPAC name
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropanamine
|
|
| Identifiers | |
| 69854-49-5 |
|
| ChEMBL | ChEMBL13530 |
| ChemSpider | 2285590 |
| Jmol 3D model | Interactive image |
| PubChem | 3017965 |
|
|
|
|
| Properties | |
| C12H17NO2 | |
| Molar mass | 207.27 g/mol |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
DMCPA, or 4-methyl-2,5-methoxyphenylcyclopropylamine, is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 15–20 mg, and the duration is listed as 4–8 hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.
Pharmacology[edit]
Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.
See also[edit]
External links[edit]
| This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |

